Literature DB >> 11990376

Pharmacogenomic-guided drug development: regulatory perspective.

L J Lesko1, J Woodcock.   

Abstract

Mesh：

Year:  2002        PMID： 11990376     DOI： 10.1038/sj.tpj.6500046

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN： 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  10 in total

Review 1.  Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact.

Authors:  Federico M Goodsaid; Shashi Amur; Jiri Aubrecht; Michael E Burczynski; Kevin Carl; Jennifer Catalano; Rosane Charlab; Sandra Close; Catherine Cornu-Artis; Laurent Essioux; Albert J Fornace; Lois Hinman; Huixiao Hong; Ian Hunt; David Jacobson-Kram; Ansar Jawaid; David Laurie; Lawrence Lesko; Heng-Hong Li; Klaus Lindpaintner; James Mayne; Peter Morrow; Marisa Papaluca-Amati; Timothy W Robison; John Roth; Ina Schuppe-Koistinen; Leming Shi; Olivia Spleiss; Weida Tong; Sharada L Truter; Jacky Vonderscher; Agnes Westelinck; Li Zhang; Issam Zineh
Journal:  Nat Rev Drug Discov       Date:  2010-06       Impact factor: 84.694

Review 2.  Translational research in central nervous system drug discovery.

Authors:  Orest Hurko; John L Ryan
Journal:  NeuroRx       Date:  2005-10

3.  Clinical implementation of genetic testing in medicine: a US regulatory science perspective.

Authors:  Lawrence J Lesko; Stephan Schmidt
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

4.  Pharmacogenomics-based practice in North Cyprus: its adoption by pharmacists and their attitudes and knowledge.

Authors:  Louai Alsaloumi; Abdikarim Abdi; Özgür Tosun; Bilgen Başgut
Journal:  Int J Clin Pharm       Date:  2019-07-02

Review 5.  Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective.

Authors:  Marc Maliepaard; Charity Nofziger; Marisa Papaluca; Issam Zineh; Yoshiaki Uyama; Krishna Prasad; Christian Grimstein; Michael Pacanowski; Falk Ehmann; Silvia Dossena; Markus Paulmichl
Journal:  Nat Rev Drug Discov       Date:  2013-02       Impact factor: 84.694

Review 6.  Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.

Authors:  Ritika Kapoor; Wei Chuen Tan-Koi; Yik-Ying Teo
Journal:  Eur J Hum Genet       Date:  2016-08-31       Impact factor: 4.246

Review 7.  Cancer biomarkers: selecting the right drug for the right patient.

Authors:  Gary J Kelloff; Caroline C Sigman
Journal:  Nat Rev Drug Discov       Date:  2012-02-10       Impact factor: 84.694

Review 8.  Advances in pharmacogenomic research and development.

Authors:  Jeanette J McCarthy
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

Review 9.  Making a new technology work: the standardization and regulation of microarrays.

Authors:  Susan Rogers; Alberto Cambrosio
Journal:  Yale J Biol Med       Date:  2007-12

Review 10.  Perspective on the Genetic Response to Antiparasitics: A Review Article.

Authors:  Patricia Alarcon-Valdes; Mariana Ortiz-Reynoso; Jonnathan Santillan-Benitez
Journal:  Iran J Parasitol       Date:  2017 Oct-Dec       Impact factor: 1.012
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.